Register entry
Union Quimico Farmaceutica SA (UQUIFA)-Sant Celoni
Data as of · How to read this entry
- Registered sites
- 0
- Active NDC listings
- 3
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
33 active NDC listings: 3 bulk ingredient. By marketing category: BULK INGREDIENT 3.
| Dosage form | NDCs |
|---|---|
| powder | 3 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| union quimico farmaceutica sa (uquifa)-sant celoni | 3 |
Catalogue
Marketed products
3| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Acyclovir | powder | 49711-0094BULK INGREDIENT |
| - | Clindamycin Phosphate | powder | 49711-0116BULK INGREDIENT |
| - | Doxylamine Succinate | powder | 49711-0114BULK INGREDIENT |
Compare
Other companies listing acyclovir
- Cardinal Health 418, Inc.34 sites · 833 NDC
- Sun Pharmaceutical Industries Limited13 sites · 918 NDC
- Zydus Lifesciences Limited12 sites · 717 NDC
- Olon USA LLC11 sites · 185 NDC
- Hetero Labs Limited8 sites · 167 NDC
- Piramal Healthcare (Canada) Limited8 sites · 86 NDC
- Alembic Pharmaceuticals Limited7 sites · 998 NDC
- Fresenius Kabi USA, LLC6 sites · 561 NDC
- Spectrum Pharmaceuticals, Inc.6 sites · 240 NDC
- Macleods Pharmaceuticals Limited5 sites · 390 NDC
Enquiry
Common questions
- Is Union Quimico Farmaceutica SA (UQUIFA)-Sant Celoni FDA approved?
- Union Quimico Farmaceutica SA (UQUIFA)-Sant Celoni holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Union Quimico Farmaceutica SA (UQUIFA)-Sant Celoni make?
- 3 products are listed under Union Quimico Farmaceutica SA (UQUIFA)-Sant Celoni in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.